Evan Barry, based in Boston, Massachusetts, United States, is currently a Principal Scientist at Merck, bringing experience from previous roles at Merck, H3 Biomedicine and AstraZeneca. Evan Barry holds a 2004 - 2009 PhD in Animal Science/ Genetics @ The University of Connecticut. With a robust skill set that includes qPCR, Cell, Genetics, Western Blotting, Stem Cells and more, Evan Barry contributes valuable insights to the industry. Evan Barry has 2 emails on RocketReach.